Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

Alliance Pharma boss trims holding

John Dawson still owns more than 56mln shares in the specialty pharmaceutical company, worth around £25mln

Alliance Pharma plc (LON:APH) chief executive John Dawson has trimmed his holding in the specialty pharmaceutical firm after selling 3mln shares.

Dawson sold the shares at a price of 45.25p per share, slightly lower than today’s opening price, netting him around £1.35mln.

Dawson still owns more than 56mln shares in the business, representing around 12% of the company’s issued share capital.

Shares were down 2% to 45p.